Allogeneic hematopoietic stem cell transplant (HSCT) is a procedure with life-threatening complications that in turn has the potential to cure a significant proportion of patients with otherwise fatal diseases. Although improvements in patient and donor selection, conditioning strategies, timing, and infection management have increased the probability of long-term survival, patients undergoing HSCT still remain exposed to a number of transplant-related morbidities. Among these chronic graft versus host disease (cGVHD), a multi-organ syndrome involving tissue inflammation and fibrosis, may affect patient quality of life in several aspects, including sexual functioning. Erectile dysfunction (ED) a multidimensional organic, relational and psychological disturbance of the erectile response has long been reported to affect a significant proportion of HSCT patients. Although predictors for ED (e.g. cardiopathy, diabetes, hypertension, obesity, depression) have been largely established in the general population few studies have addressed any variables specifically associated to ED in HSCT patients.
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience
Angelo Andreini;Nicola Zampieri;Claudio Costantini;Giovanni Malerba;Costanza Bruno;Gian Luca Salvagno;Giuseppe Francia;Michela Rimondini;Isacco Ferrarini;Giuseppe Lippi;Achille Ambrosetti;Fabio Benedetti;Cristina Tecchio
2018-01-01
Abstract
Allogeneic hematopoietic stem cell transplant (HSCT) is a procedure with life-threatening complications that in turn has the potential to cure a significant proportion of patients with otherwise fatal diseases. Although improvements in patient and donor selection, conditioning strategies, timing, and infection management have increased the probability of long-term survival, patients undergoing HSCT still remain exposed to a number of transplant-related morbidities. Among these chronic graft versus host disease (cGVHD), a multi-organ syndrome involving tissue inflammation and fibrosis, may affect patient quality of life in several aspects, including sexual functioning. Erectile dysfunction (ED) a multidimensional organic, relational and psychological disturbance of the erectile response has long been reported to affect a significant proportion of HSCT patients. Although predictors for ED (e.g. cardiopathy, diabetes, hypertension, obesity, depression) have been largely established in the general population few studies have addressed any variables specifically associated to ED in HSCT patients.File | Dimensione | Formato | |
---|---|---|---|
_system_appendPDF_proof_hi.pdf
non disponibili
Descrizione: Articolo principale
Tipologia:
Documento in Post-print
Licenza:
Accesso ristretto
Dimensione
451.75 kB
Formato
Adobe PDF
|
451.75 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.